Search
Welcome to Saul Ewing’s Public Companies Quarterly Update series. Our intent is to, on a quarterly basis, highlight important legal developments of which we think public companies should be aware. This edition is related to developments during the first quarter of 2024. If you would like to discuss...
This checklist highlights certain considerations for companies preparing to file annual reports on Form 10-K for the calendar year ended 2023 and is intended to serve as a focused resource highlighting changes in disclosure requirements and points of emphasis for the Securities and Exchange...
Welcome to Saul Ewing’s Public Companies Quarterly Update series. Our intent is to, on a quarterly basis, highlight important legal developments of which we think public companies should be aware. This edition is related to developments during the fourth quarter of 2023. If you would like to discuss...
Welcome to Saul Ewing’s Public Companies Quarterly Update series. Our intent is to, on a quarterly basis, highlight important legal developments of which we think public companies should be aware. This edition is related to developments during the second quarter of 2023. If you would like to discuss...
BOSTON, MA (February 7, 2023) – Jon Barooshian and Patrick Tracey bring a combined five decades of experience as litigators to their new roles as partners in the firm’s Boston office. Mr. Barooshian will focus his practice on white collar and government enforcement matters and tax controversies...
THE CLASS ACTION MECHANISM, RISKS, AND STRATEGIES TO PROTECT YOUR COMPANY Jon Singer, a Partner in the Firm's Class Actions Practice, will be speaking during the Association of Corporate Counsel's July New to In-House Update. This session will provide a high level overview intended to educate new in...
Industry-Specific, Business-Focused Legal Advice Increased pricing pressure combined with a rise in generic competition and continued regulatory uncertainty have squeezed the margins of life sciences companies. Helping navigate this ever-shifting terrain, Saul Ewing’s Life Sciences Practice consists...
A life sciences patent attorney with a Ph.D. in virology and cell and molecular biology, Kathryn Doyle represents universities and companies throughout the United States in identifying, protecting and enforcing their intellectual property in the areas of biotechnology, pharmaceuticals, agriculture...
David Berk counsels families and their businesses, entrepreneurs and start-up companies in taxation, structuring transactions, contract negotiations and governance issues. David also advises clients on corporate succession planning, trust and estate planning, insurance and retirement planning and...
Ted Baines is a partner and past chair of Saul Ewing's Litigation Department. He focuses his litigation practice on commercial contract, insurance, shareholder disputes, including shareholder demand responses, real estate, construction, and the defense of mass torts involving deaths or catastrophic...
Gianna Arnold helps companies protect, leverage and enforce their intellectual property and develop and memorialize strategic alliances in service to their goal of enhancing their value. Her understanding of the importance of these assets to the bottom line of a business stems in part from her past...
Eric Orlinsky co-chairs the firm's Corporate Practice and its Private Equity/Venture Capital subgroup and concentrates his practice in general business and securities law and counsels clients in private equity and venture capital investments, public and private offerings of debt and equity...